SMYD3 has been highly correlated, most notably with breast, hepatocellular, and colorectal carcinomas as well as with lung and pancreatic ductal adenocarcinomas [2,30,31,120]. This evidence concerns the gene SMYD3 and pancreatic ductal adenocarcinoma.